Segment Information (Tables)

9 Months Ended

Sep. 30, 2017

Segment Reporting [Abstract]

Selected financial info by reportable segment

Selected financial information by reportable segment is presented below (in thousands):

	Three Months Ended September 30,						Nine Months Ended September 30,
	2017			2016			2017			2016
Revenues, net:
Prescription Pharmaceuticals	$	186,988		$	268,880		$	607,012		$	784,644
Consumer Health	15,440			15,215			47,976			48,532
Total revenues, net	202,428			284,095			654,988			833,176
Gross Profit:
Prescription Pharmaceuticals	91,454			163,300			328,877			482,427
Consumer Health	6,509			6,927			21,185			22,590
Total gross profit	97,963			170,227			350,062			505,017
Operating expenses	88,540			83,399			251,276			238,242
Operating income	9,423			86,828			98,786			266,775
Other expenses, net	(11,360		)	(11,614		)	(28,647		)	(44,714		)
Income (loss) before income taxes	$	(1,937	)	$	75,214		$	70,139		$	222,061